Author:
Corradini P,Tarella C,Zallio F,Dodero A,Zanni M,Valagussa P,Gianni A M,Rambaldi A,Barbui T,Cortelazzo S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference27 articles.
1. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Brière J, Haioun C et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d’Etudes des Lymphomes de l’Adulte (GELA). Blood 1998; 92: 76–82.
2. Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn J et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493–1498.
3. Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C et al. Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004; 350: 1287–1295.
4. Rodriguez J, Munsell M, Yazji S, Hagemeister F, Younes A, Andersson B et al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19: 3766–3770.
5. Song KW, Mollee P, Keating A, Crump M . Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 2003; 120: 978–985.
Cited by
218 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献